| 标题 |
Preliminary Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of KT-333, a Targeted Protein Degrader of STAT3, in Patients with Relapsed or Refractory Lymphomas, Large Granular Lymphocytic Leukemia, and Solid Tumors |
| 网址 | |
| DOI |
10.1182/blood-2023-181130
doi
|
| 其它 |
期刊:Blood 作者:Aditi Shastri; Eric J Feldman; Alexander N Starodub; Tatyana Feldman; Cristina P Rodriguez; et al 出版日期:2023-11-02 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)